Treatment of Hypertriglyceridemia
The treatment of hypertriglyceridemia should begin with lifestyle modifications for all patients, followed by pharmacologic therapy based on triglyceride levels, with fibrates being first-line for severe hypertriglyceridemia (≥500 mg/dL) and statins for moderate hypertriglyceridemia with elevated cardiovascular risk. 1, 2
Classification of Hypertriglyceridemia
- Hypertriglyceridemia is classified by severity: Normal (<150 mg/dL), Mild (150-199 mg/dL), Moderate (200-499 mg/dL), Severe (500-999 mg/dL), and Very severe (≥1000 mg/dL) 1
- Mild to moderate hypertriglyceridemia is associated with increased cardiovascular risk, while severe and very severe levels increase the risk of pancreatitis 2
Initial Assessment
- Evaluate for secondary causes including excessive alcohol intake, uncontrolled diabetes, hypothyroidism, renal disease, liver disease, and certain medications (thiazides, beta-blockers, estrogen, corticosteroids) 1, 2
- Assess cardiovascular risk factors, including family history, central obesity, hypertension, and abnormal glucose metabolism 1
- Determine the risk of pancreatitis, particularly with triglycerides ≥500 mg/dL 1
Lifestyle Interventions
- Target a 5-10% weight loss, which can reduce triglycerides by up to 20% 1, 2, 3
- In some patients, weight loss can reduce triglyceride levels by up to 70% 1
- Restrict added sugars to <6% of total daily calories and limit total fat to 30-35% of total daily calories for mild to moderate hypertriglyceridemia 1, 2
- For severe hypertriglyceridemia (500-999 mg/dL), further restrict added sugars and total fat to 20-25% of total daily calories 2, 4
- For very severe hypertriglyceridemia (≥1,000 mg/dL), eliminate added sugars completely and restrict total fat to 10-15% of daily calories 1, 2
- Engage in at least 150 minutes/week of moderate-intensity or 75 minutes/week of vigorous aerobic activity 1, 2
- Limit or completely avoid alcohol consumption, especially in patients with severe hypertriglyceridemia 1, 2, 4
- Low-carbohydrate diets are more effective at lowering triglycerides than low-fat diets 1, 4
Pharmacologic Therapy Based on Triglyceride Levels
For Severe to Very Severe Hypertriglyceridemia (≥500 mg/dL)
- Fibrates are the first-line drug therapy to reduce the risk of pancreatitis 1, 2, 5
- Immediate pharmacologic intervention is required to reduce the risk of acute pancreatitis 1
- Prescription omega-3 fatty acids (2-4g/day) can be used as adjunctive therapy 1, 2
For Moderate Hypertriglyceridemia (200-499 mg/dL)
- Consider statins if there is elevated LDL-C or increased cardiovascular risk, which can provide a 10-30% reduction in triglycerides 1, 2
- If triglycerides remain elevated after statin therapy, consider adding prescription omega-3 fatty acids (2-4g/day) 1
- Target non-HDL-C of <130 mg/dL 1
- Fibrates may be considered if triglycerides remain significantly elevated despite lifestyle modifications and statin therapy 1
Special Considerations
- Optimize glycemic control in patients with diabetes, as it can significantly improve triglyceride levels 1, 2, 4
- For patients with triglycerides ≥500 mg/dL, prioritize aggressive triglyceride lowering to reduce the risk of pancreatitis before focusing on LDL-C goals 1, 2
- Monitor for potential drug interactions, particularly when combining lipid-lowering medications 2
- Avoid fibrate-statin combinations when possible due to increased risk of myositis 4
Monitoring and Follow-up
- Reassess fasting lipid panel in 6-12 weeks after implementing lifestyle modifications 1, 2
- Continue to monitor for secondary causes of hypertriglyceridemia 1